Bone Biologics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Mitchell P. Kopin(9.99%),Daniel B. Asher(9.99%), etc.
Bone Biologics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Ionic Ventures, LLC(6.5%),Ionic Management, LLC(6.5%), etc.
Bone Biologics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Walleye Capital LLC(0.0%)
Bone Biologics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lind Global Fund II LP(6.0%),Lind Global Partners II LLC(6.0%), etc.
Bone Biologics | 4: Statement of changes in beneficial ownership of securities-Officer Walsh Deina H
Bone Biologics | 4: Statement of changes in beneficial ownership of securities-Officer Frelick Jeff
Bone Biologics | 4: Statement of changes in beneficial ownership of securities-Director Gagnon Robert E.
Bone Biologics | 3: Initial statement of beneficial ownership of securities-Director Gagnon Robert E.
Bone Biologics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
Bone Biologics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Ionic Ventures, LLC(9.99%),Brendan O’Neil(9.99%), etc.
Bone Biologics | D: Filing D
Bone Biologics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Mitchell P. Kopin(4.99%),Daniel B. Asher(4.99%), etc.
Bone Biologics | 4: Statement of changes in beneficial ownership of securities-Director Lucera Erick
Bone Biologics | 4: Statement of changes in beneficial ownership of securities-Director Angle Siddhesh Rajendra
Bone Biologics | 4: Statement of changes in beneficial ownership of securities-Director Stroever Bruce
Bone Biologics | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Walsh Deina H
Bone Biologics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Frelick Jeff
Bone Biologics | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Walsh Deina H
Bone Biologics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Frelick Jeff
Bone Biologics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Lind Global Fund II LP(6.5%),Lind Global Partners II LLC(6.5%), etc.
No Data